共 50 条
- [42] Editorial Comment to Efficacy and safety of tadalafil 5 mg once-daily in Asian men with both lower urinary tract symptoms associated with benign prostatic hyperplasia and erectile dysfunction: A phase 3, randomized, double-blind, parallel, placebo- and tamsulosin-controlled study INTERNATIONAL JOURNAL OF UROLOGY, 2019, 26 (02) : 200 - 201
- [43] Impact of cardiovascular risk factors and related comorbid conditions and medical therapy reported at baseline on the treatment response to tadalafil 5mg once-daily in men with lower urinary tract symptoms associated with benign prostatic hyperplasia: an integrated analysis of four randomised, double-blind, placebo-controlled, clinical trials INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2015, 69 (12) : 1496 - 1507
- [44] Response to daily 10 Mg alfuzosin predicts acute urinary retention and benign prostatic hyperplasia related surgery in men with lower urinary tract symptoms JOURNAL OF UROLOGY, 2006, 176 (03): : 1051 - 1056
- [48] EFFICACY FOR ERECTILE FUNCTION AND LOWER URINARY TRACT SYMPTOMS OF MIRODENAFIL 50 MG ONCE DAILY IN PATIENTS WITH ERECTILE DYSFUNCTION: A MULTICENTER, RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL JOURNAL OF UROLOGY, 2012, 187 (04): : E600 - E601